Misolfa (Dienogest, Ethinylestradiol)

Dienogest and Ethinylestradiol, the active ingredients in Misolfa, are a combined oral contraceptive presented as a tablet for oral use. It is indicated for prevention of pregnancy in women of reproductive age. GNH USA supplies Misolfa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Misolfa is a combined oral contraceptive that acts on the hormonal regulation of the menstrual cycle to prevent pregnancy. - Contraception: provides reliable birth control for women of childbearing age. - Menstrual cycle regulation: helps achieve more regular and predictable menstrual bleeding. - Acne treatment: may improve hormonal acne by reducing androgen‑mediated sebum production.

Misolfa may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Breast tenderness: temporary swelling or discomfort. - Headache: occasional mild to moderate pain. - Spotting or breakthrough bleeding: irregular bleeding between periods. - Weight change: slight increase or decrease. - Mood swings: changes in emotional state.

Serious or Rare Side Effects: - Thromboembolic events: deep vein thrombosis or pulmonary embolism. - Hypertension: elevated blood pressure requiring medical attention. - Liver disorders: hepatic adenoma or cholestasis. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Visual disturbances: sudden loss of vision or eye pain. - Stroke: neurological symptoms indicating cerebrovascular accident.

Before prescribing Misolfa, clinicians should evaluate patient risk factors and counsel on safe use. - Assess cardiovascular risk: avoid in patients with history of thrombosis or uncontrolled hypertension. - Screen smoking status: contraindicated in women over 35 who smoke. - Review hepatic function: liver disease may alter hormone metabolism. - Consider drug interactions: evaluate concomitant medications that affect hormone levels. - Avoid use in pregnancy: discontinue immediately if pregnancy is confirmed. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Misolfa can interact with several drug classes, influencing its efficacy or safety.

Major Interactions (Avoid): - Enzyme‑inducing anticonvulsants (e.g., carbamazepine, phenytoin): may markedly reduce contraceptive effectiveness. - Rifampicin or other strong CYP3A4 inducers: can lower plasma hormone concentrations. - Anticoagulants (e.g., warfarin): may increase INR and bleeding risk.

Moderate Interactions (Monitor Closely): - Certain antibiotics (e.g., ampicillin, tetracycline): may slightly diminish contraceptive reliability. - Antifungal agents (e.g., ketoconazole, itraconazole): can raise hormone levels, increasing side‑effect potential. - St. John’s wort: herbal supplement that may reduce efficacy. - Selective serotonin reuptake inhibitors: may increase risk of mood changes.